Robert M. Califf

Robert M.
Califf currently works at Keystone Symposia, as Director, Critical Path Institute, as Director from 2021, US Food & Drug Administration, as Commissioner from 2022, National Academy of Medicine (United States), as Member, and Duke University Medical Center, as Vice Chancellor-Clinical & Translational Research from 2013.
Dr. Califf also formerly worked at Clinical Trials Transformation Initiative, as Co-Chairman, Cytokinetics, Inc., as Independent Director from 2018 to 2022, Portola Pharmaceuticals LLC, as Independent Director from 2012 to 2015, Duke Clinical Research Institute, as Founding Director, Proventus, Inc., as Director, Nitrox LLC, as Director, Duke Translational Medicine Institute, as Director, Centessa Pharmaceuticals Plc, as Director from 2021 to 2022, Duke University, as Vice Chancellor-Clinical & Translational Research, US Food & Drug Administration, as Commissioner from 2016 to 2017, National Library of Medicine, as Member-Scientific Counselors, and Alphabet, Inc., as Head-Strategy & Policy.
Dr. Califf received his undergraduate degree and doctorate degree from Duke University School of Medicine.